Galectin (GALT) Posts Q2 Loss of 17c/Share

Galectin (NASDAQ: GALT) reported Q2 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Galectin (GALT) click here.

You May Also Be Interested In

• UBS sees a negative catalyst ahead for Nike: Here’s what to watch
• Copart launches $10.50-per-share tender offer to acquire ACV
• Lennar Corp. (LEN) Misses Q3 EPS by 10c